InnoCare Pharma Ltd. (INCPF)
1.55
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
InnoCare Pharma Debt to Equity Ratio : 0.2911 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2911 |
| March 31, 2026 | 0.2465 |
| December 31, 2025 | 0.2085 |
| September 30, 2025 | 0.2499 |
| June 30, 2025 | 0.2295 |
| March 31, 2025 | 0.2289 |
| December 31, 2024 | 0.2341 |
| September 30, 2024 | 0.2276 |
| June 30, 2024 | 0.2433 |
| March 31, 2024 | 0.0583 |
| December 31, 2023 | 0.2315 |
| September 30, 2023 | 0.01 |
| June 30, 2023 | 0.1726 |
| March 31, 2023 | 0.0453 |
| December 31, 2022 | 0.0452 |
| September 30, 2022 | 0.2029 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | 0.233 |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -1.780 |
| September 30, 2019 | -2.560 |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -3.278 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.653B |
| Total Liabilities (Quarterly) | 475.27M |
| Shareholders Equity (Quarterly) | 1.131B |
| Current Ratio | 4.215 |
| Net Debt Paydown Yield | -0.85% |